Breaking News

Quincy Bioscience Receives NSF GMP Recertification

By Kristin Brooks | February 28, 2014

Manufacturing methods in accordance with FDA’s 21 CFR part 111

Quincy Bioscience has received recertification of its GMP facilities registered by NSF International for 2014. The GMP registration verifies that the company has the proper methods, equipment, facilities, and controls in place for producing dietary supplement products in accordance with the FDA’s 21 CFR part 111 regulations on manufacturing, packaging, and distribution.
 
"We're proud to maintain this important recognition for all of our locations," said Mark Underwood, president and co-founder of Quincy Bioscience. "We take good manufacturing practices very seriously in every department of our organization and we're pleased that NSF continues to acknowledge our practice of excellence."
 

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors